8-K
filed September 20, 2021, 7:59 PM ET
ticker DNA
CIK 0001830214
M&A
confidence high
sentiment positive
materiality 0.85
Ginkgo Bioworks completes $15.8B SPAC merger; begins NYSE trading under DNA
Ginkgo Bioworks Holdings, Inc.
- Transaction valued at ~$15.8B; Old Ginkgo equity holders received ~49.08 New Ginkgo shares per old share.
- PIPE investment of $760M (76M shares at $10.00) raised concurrently with closing.
- Earn-out shares up to 188.7M shares vest based on stock price targets ($12.50/$15.00/$17.50/$20.00) over 5 years.
- Post-closing shares outstanding: ~1.75B Class A and B common (excluding earn-out and warrants); total ~2.01B.
- Class A common and warrants began trading on NYSE Sept 17, 2021 under symbols DNA and DNA.WS.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Reshma Shetty was appointed as President and Chief Operating Officer at Ginkgo Bioworks Holdings, Inc..
- Action
- appointed
- Role
- President and Chief Operating Officer
Exact text from the filing
Ms. Shetty was appointed as President and Chief Operating Officer;
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Jason Kelly was appointed as Director at Ginkgo Bioworks Holdings, Inc..
- Action
- appointed
- Role
- Director
Exact text from the filing
Jason Kelly, Reshma Shetty, Arie Belldegrun, Marijn Dekkers, Christian Henry, Reshma Kewalramani, Shyam Sankar and Harry E. Sloan were appointed as directors of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Dennis A. Miller departed as Director at Ginkgo Bioworks Holdings, Inc..
- Action
- ceased
- Role
- Director
Exact text from the filing
Scott M. Delman, Joshua Kazam, Isaac Lee, Timothy Leiweke, Dennis A. Miller, Laurence E. Paul, and Harry E. Sloan ceased serving on SRNG’s board of directors.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Arie Belldegrun was appointed as Director at Ginkgo Bioworks Holdings, Inc..
- Action
- appointed
- Role
- Director
Exact text from the filing
Jason Kelly, Reshma Shetty, Arie Belldegrun, Marijn Dekkers, Christian Henry, Reshma Kewalramani, Shyam Sankar and Harry E. Sloan were appointed as directors of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Mark Dmytruk was appointed as Chief Financial Officer at Ginkgo Bioworks Holdings, Inc..
- Action
- appointed
- Role
- Chief Financial Officer
Exact text from the filing
Mark Dmytruk was appointed as Chief Financial Officer.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Christian Henry was appointed as Director at Ginkgo Bioworks Holdings, Inc..
- Action
- appointed
- Role
- Director
Exact text from the filing
Jason Kelly, Reshma Shetty, Arie Belldegrun, Marijn Dekkers, Christian Henry, Reshma Kewalramani, Shyam Sankar and Harry E. Sloan were appointed as directors of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Laurence E. Paul departed as Director at Ginkgo Bioworks Holdings, Inc..
- Action
- ceased
- Role
- Director
Exact text from the filing
Scott M. Delman, Joshua Kazam, Isaac Lee, Timothy Leiweke, Dennis A. Miller, Laurence E. Paul, and Harry E. Sloan ceased serving on SRNG’s board of directors.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Reshma Kewalramani was appointed as Director at Ginkgo Bioworks Holdings, Inc..
- Action
- appointed
- Role
- Director
Exact text from the filing
Jason Kelly, Reshma Shetty, Arie Belldegrun, Marijn Dekkers, Christian Henry, Reshma Kewalramani, Shyam Sankar and Harry E. Sloan were appointed as directors of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Jason Kelly was appointed as Chief Executive Officer at Ginkgo Bioworks Holdings, Inc..
- Action
- appointed
- Role
- Chief Executive Officer
Exact text from the filing
Mr. Kelly was appointed as the Company’s Chief Executive Officer;
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Shyam Sankar was appointed as Director at Ginkgo Bioworks Holdings, Inc..
- Action
- appointed
- Role
- Director
Exact text from the filing
Jason Kelly, Reshma Shetty, Arie Belldegrun, Marijn Dekkers, Christian Henry, Reshma Kewalramani, Shyam Sankar and Harry E. Sloan were appointed as directors of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Harry E. Sloan departed as Director at Ginkgo Bioworks Holdings, Inc..
- Action
- ceased
- Role
- Director
Exact text from the filing
Scott M. Delman, Joshua Kazam, Isaac Lee, Timothy Leiweke, Dennis A. Miller, Laurence E. Paul, and Harry E. Sloan ceased serving on SRNG’s board of directors.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Harry E. Sloan was appointed as Director at Ginkgo Bioworks Holdings, Inc..
- Action
- appointed
- Role
- Director
Exact text from the filing
Jason Kelly, Reshma Shetty, Arie Belldegrun, Marijn Dekkers, Christian Henry, Reshma Kewalramani, Shyam Sankar and Harry E. Sloan were appointed as directors of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Joshua Kazam departed as Director at Ginkgo Bioworks Holdings, Inc..
- Action
- ceased
- Role
- Director
Exact text from the filing
Scott M. Delman, Joshua Kazam, Isaac Lee, Timothy Leiweke, Dennis A. Miller, Laurence E. Paul, and Harry E. Sloan ceased serving on SRNG’s board of directors.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Scott M. Delman departed as Director at Ginkgo Bioworks Holdings, Inc..
- Action
- ceased
- Role
- Director
Exact text from the filing
Scott M. Delman, Joshua Kazam, Isaac Lee, Timothy Leiweke, Dennis A. Miller, Laurence E. Paul, and Harry E. Sloan ceased serving on SRNG’s board of directors.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Reshma Shetty was appointed as Director at Ginkgo Bioworks Holdings, Inc..
- Action
- appointed
- Role
- Director
Exact text from the filing
Jason Kelly, Reshma Shetty, Arie Belldegrun, Marijn Dekkers, Christian Henry, Reshma Kewalramani, Shyam Sankar and Harry E. Sloan were appointed as directors of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Isaac Lee departed as Director at Ginkgo Bioworks Holdings, Inc..
- Action
- ceased
- Role
- Director
Exact text from the filing
Scott M. Delman, Joshua Kazam, Isaac Lee, Timothy Leiweke, Dennis A. Miller, Laurence E. Paul, and Harry E. Sloan ceased serving on SRNG’s board of directors.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Timothy Leiweke departed as Director at Ginkgo Bioworks Holdings, Inc..
- Action
- ceased
- Role
- Director
Exact text from the filing
Scott M. Delman, Joshua Kazam, Isaac Lee, Timothy Leiweke, Dennis A. Miller, Laurence E. Paul, and Harry E. Sloan ceased serving on SRNG’s board of directors.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Marijn Dekkers was appointed as Director at Ginkgo Bioworks Holdings, Inc..
- Action
- appointed
- Role
- Director
Exact text from the filing
Jason Kelly, Reshma Shetty, Arie Belldegrun, Marijn Dekkers, Christian Henry, Reshma Kewalramani, Shyam Sankar and Harry E. Sloan were appointed as directors of the Company.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.